Type: Poster
Juan Carlos Hernandez Boluda, MD, PhD1*, Adrian Mosquera Orgueira, MD, PhD2*, Luuk Gras3*, Linda Koster4*, Joe Tuffnell4*, Nicolaus Kröger, MD5*, Emanuele Angelucci, MD6, Thomas Schroeder7*, Marie Robin, MD8*, Martin Bornhäuser, MD9*, Jakob Passweg Sr.10, Igor Wolfgang Blau, MD, PhD11*, Ibrahim Yakoub-Agha, MD, PhD12*, Annoek E. C. Broers, MD13*, Matthias Stelljes, MD14*, Henrik Sengeloev15*, Jan Vydra, MD, PhD16*, Uwe Platzbecker, MD17, Jurgen Kuball, MD18, Frederic Baron Sr.19*, Kristina Carlson20, Javier Rojas Sr.21*, Carlos Pérez Míguez22*, Davide Crucitti23*, Kavita K Raj, MD, PhD, FRCP, FRCPath24, Joanna Drozd-Sokolowska25*, Giorgia Battipaglia26*, Nicola Polverelli27*, Tomasz Czerw, MD28* and Donal P McLornan, MD, PhD29*
1Hospital Clínico Universitario-INCLIVA, VALENCIA, Spain
2University Hospital of Santiago de Compostela, Department of Hematology, IDIS, SANTIAGO DE COMPOSTELA, Spain
3EBMT, Leiden, Netherlands
4EBMT Leiden Study Unit, Leiden, Netherlands
5University Hospital Eppendorf, Hamburg, Germany, Hamburg, Germany
6Hematology and Cellular Therapy, IRCCS Ospedale Policlinico San Martino, Genova, ITA
7Dept. of Hematology and Stem Cell Transplantation West German Cancer Centre University Hospital Essen Essen, Germany, Essen, Germany
8Hopital Saint Louis, APHP, Paris, France
9Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany
10University Hospital Basel, Basel, Switzerland
11Medizinische Klinik m. S. Hämatologie, Onkologie und Tumorimmunologie, Berlin, Germany
12CHU de Lille, Université de Lille, INSERM U1286, Infinite, 59000, Lille, France
13Erasmus MC Cancer Institute, Rotterdam, Netherlands
14Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany
15Rigshospitalet, Copenhagen, Denmark
16Institute of Haematology and Blood Transfusion, Prague, Czech Republic
17Department for Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University of Leipzig Medical Center, Leipzig, Germany
18Department of Hematology, University Medical Centre, Utrecht, Netherlands
19University of Liege, Liege, Belgium
20Uppsala University, Uppsala, SWE
21IDIS, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain
22Computational Hematology & Genomics Group (GrHeCo-Xen), Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain
23University Hospital of Santiago de Compostela, Santiago de Compostela, Spain
24Department of Haematology, University College London Hospitals NHS Trust, London, United Kingdom
25Central Clinical Hospital. The Medical University of Warsaw, Warsaw, Poland
26Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy, Naples, ITA
27Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
28Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, POL
29Department of Haematology, University College London Hospitals NHS Trust, London, ENG, United Kingdom
Juan Carlos Hernandez Boluda, MD, PhD1*, Vipul Sharad Sheth, DM, MBBS, MD2*, Simona Iacobelli3*, Linda Koster4*, Nicolaus Kröger, MD5*, Simona Sica, MD, PhD6*, Thomas Schroeder7*, Regis Peffault De Latour8*, Emanuele Angelucci, MD9, Didier Blaise, MD, PhD10, Henrik Sengeloev11*, Jakob Passweg Sr.12, Matthias Stelljes, MD13*, Robert Zeiser, MD14, Ibrahim Yakoub-Agha, MD, PhD15*, Andrew Clark16*, Urpu Salmenniemi, MD17*, Piero Galieni, MD18*, Werner Rabitsch19*, Kavita K Raj, MD, PhD, FRCP, FRCPath20, Joanna Drozd-Sokolowska, MD, PhD21*, Marie Robin, MD22*, Giorgia Battipaglia23*, Nicola Polverelli24, Tomasz Czerw, MD25* and Donal P McLornan, MD, PhD26*
1Hospital Clínico Universitario-INCLIVA, VALENCIA, Spain
2Rajiv Gandhi Cancer Research Institute and Research center, New Delhi, India
3Centro Di Biostatistica E Bioinformatica Università Tor Vergata, Rome, ITA
4EBMT Leiden Study Unit, Leiden, Netherlands
5University Medical Center Hamburg, Hamburg, Germany
6UNIVERSITA' CATTOLICA SACRO CUORE, ROME, ITA
7Dept. of Hematology and Stem Cell Transplantation West German Cancer Centre University Hospital Essen Essen, Germany, Essen, Germany
8BMT unit, Hôpital Saint-Louis,, Paris, France
9Hematology and Cellular Therapy, IRCCS Ospedale Policlinico San Martino, Genova, ITA
10Program of Transplant and cellular immunotherapy, Department of Hematology, Institut Paoli Calmettes, Marseille, France
11Rigshospitalet, Copenhagen, Denmark
12University Hospital Basel, Basel, Switzerland
13Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany
14University of Freiburg, Faculty of Medicine, Albert Ludwigs University (ALU), Freiburg, Germany, Freiburg, Germany, Freiburg, Germany
15CHU de Lille, Université de Lille, INSERM U1286, Infinite, 59000, Lille, France
16Glasgow Roya Infirmary, Glasgow, United Kingdom
17Dept of Hematology, Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki, Finland
18UOC Hematology, Mazzoni Hospital-Ascoli Piceno, Ascoli Piceno, Italy
19Bone Marrow Transplantation Unit, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria
20Department of Haematology, University College London Hospitals NHS Trust, London, United Kingdom
21Central Clinical Hospital, The Medical University of Warsaw, Warsaw, Poland
22Hopital Saint Louis, APHP, Paris, France
23Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy, Naples, ITA
24Unit of Bone Marrow Transplantation – Division of Hematology,, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
25Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, POL
26Department of Haematology, University College London Hospitals NHS Trust, London, ENG, United Kingdom
Radwan Massoud, MD, BS1*, Sarah Flossdorf2*, Franziska Hanke3*, Thomas Schroeder4*, Wolfgang Andreas Bethge, MD5*, Robert Zeiser, MD6, Caroline Pabst7*, Gerald Wulf8*, Elisa Sala9*, Inken Hilgendorf, MD10*, Christof Scheid, MD11, Matthias Edinger, MD12*, Friedrich Stölzel13*, Igor Wolfgang Blau, MD, PhD14*, Matthias Stelljes, MD15, Guido Kobbe, MD16*, Uwe Platzbecker, MD17, Jörg Bittenbring18*, Matthias Eder, MD19*, Katharina Fleischhauer, MD20*, Andreas Burchert, MD21, Christoph Schmid, MD22* and Nicolaus Kroeger23
1Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Hamburg, Germany
2Institute for Medical Informatics, Biometry and Epidemiology (IMIBE), University of Duisburg-Essen, Essen, Germany
3German Registry for Hematopoietic Stem Cell Transplantation and Cell Therapy (DRST), Ulm, Germany
4Dept. of Hematology and Stem Cell Transplantation West German Cancer Centre University Hospital Essen Essen, Germany, Duisburg, Germany
5Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tübingen, Germany
6University of Freiburg, Faculty of Medicine, Albert Ludwigs University (ALU), Freiburg, Germany, Freiburg, Germany, Freiburg, Germany
7University Hospital Heidleberg, Heidelberg, DEU
8Department of Hematology and Medical Oncology, University Hospital Goettingen, Goettingen, Germany
9Department of Internal Medicine , Hematology and Oncology, University Hospital of Ulm, Ulm, Germany
10Department of Internal Medicine , Hematology and Oncology, University Hospital Jena , Germany., Jena, Germany
11Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany, Cologne, Germany
12Internal Medicine III - Hematology and Oncology, University Hospital Regensburg, Regensburg, DEU
13Division of Stem Cell Transplantation and Cellular Immunotherapies, University Hospital Schleswig-Holstein, Kiel, Germany
14Medical Clinic, Charité University Medicine Berlin, Berlin, Germany, Berlin, Germany
15Department of Medicine A (Hematology, Hemostaseology, Oncology, Pneumology), University of Muenster, Muenster, Germany
16Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany
17Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University Medical Center Leipzig, Leipzig, Germany
18Department of Internal Medicine , Hematology and Oncology, University Hospital Homburg , Germany, Homburg/Saar, DEU
19Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
20Institute for Experimental Cellular Therapy, University Hospital Essen, Essen, Germany
21Department of Hematology, Oncology and Immunology, University Hospital Marburg, Marburg, Germany
22Department of Hematology, University Hospital Augsburg, Augsburg, Germany
23Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Mattia Algeri, MD1,2*, Michele Massa1*, Daria Pagliara, MD, PhD1*, Valentina Bertaina, PhD1*, Federica Galaverna, MD, PhD1*, Ilaria Pili1*, Giuseppina Li Pira, PhD1*, Roberto Carta, MD1*, Francesco Quagliarella, MD3*, Rita Maria Pinto, MD1*, Chiara Rosignoli, MD1*, Barbarella Lucarelli, MD1*, Maria Giuseppina Cefalo, MD1*, Emilia Boccieri, MD1*, Francesca Benini1*, Francesca Del Bufalo, MD, PhD1*, Marco Becilli, MD1*, Pietro Merli, MD1*, Gerhard Zugmaier, M.D., Ph.D4 and Franco Locatelli, MD5,6
1Department of Hematology-Oncology and Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Italy
2Magna Graecia University of Catanzaro, Catanzaro, Calabria, Italy
3Department of Hematology-Oncology and Cell and Gene Therapy, IRCCS Bambino Gesù Children Hospital, Rome, Italy
4Amgen Research Munich, Munich, Germany
5IRCCS Bambino Gesù Children's Hospital, Rome, Italy
6Catholic University of the Sacred Heart, Rome, Italy
Yishan Ye, MD1*, Myriam Labopin2*, Ibrahim Yakoub-Agha, MD, PhD3*, Gerard Socie4, Didier Blaise, MD5*, Tobias Gedde-Dahl, MD6*, Igor Wolfgang Blau, MD, PhD7*, Anna Maria Raiola8*, Jennifer Byrne, FRCP FRCPath PhD9*, Etienne Daguindau, MD10*, Hélène Labussière-Wallet, MD11*, Anne Huynh, MD12*, Ali Bazarbachi, MD, PhD13, Arnon Nagler, MD14, Eolia Brissot15, Lin Li16*, Yi Luo17, Jimin Shi1*, Mohamad Mohty, MD, PhD18, He Huang19* and Fabio Ciceri20*
1Bone Marrow Transplantation Center of The First Affiliated Hospital Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
2EBMT Statistical Unit, Sorbonne University, Saint-Antoine Hospital, AP-HP, INSERM UMRs 938, Paris, France
3Lille University Hospital, Lille, France
4Hematology Transplantation, Paris, France
5Programme de Transplantation & Thérapie Cellulaire, Centre de Recherche en Cancérologie de Marseille, Marseille, France
6Oslo University Hospital, Rikshospitalet, Oslo, Norway
7Medizinische Klinik m. S. Hämatologie , Onkologie und Tumorimmunologie, Berlin, Germany, Berlin, Germany
8IRCCS Ospedale Policlinico San Martino, Genova, Italy, Genova, Italy
9Nottingham University Hospitals NHS Trust, Nottingham, GBR
10Department of Clinical Hematology, Hopital Jean Minjoz, Service d'Onco-hématologie, Besançon, France
11Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France
12Hematology Department, Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France
13American University of Beirut Dept. of Medicine, Beirut, Lebanon
14Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Aviv, Israel
15Hematology Department, Hôpital Saint Antoine, Service d'Hématologie et Thérapie Cellulaire, Paris, France, Paris, France
16The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
17Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Bone Marrow Transplantation, the First Affiliated Hospital of Zhejiang Universit, Hangzhou, China
18Sorbonne University, Hôpital Saint-Antoine, and INSERM UMRs938, Paris, France
19Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
20Unit of Hematology and Stem Cell Transplantation, Ospedale San Raffaele, University Vita-Salute San Raffaele, Milan, Italy
Martin G. Sauer, MD1, Peter Lang, MD2*, Michael H Albert3*, Peter Bader4,5, Ursula Creutzig6*, Matthias Eyrich, MD7*, Johann Greil8*, Bernd Gruhn9*, Wolfgang Holter, MD10*, Thomas Klingebiel, MD11*, Bernhard Kremens12*, Christine Mauz-Körholz13*, Roland Meisel, MD14*, Kirsten Mischke6*, Ingo Muller15*, Charlotte Marie Niemeyer, MD16, Christina Peters17,18*, Dirk Reinhardt, MD19,20, Birgit Burkhardt, MD, PhD21,22, Paul-Gerhardt Schlegel, MD23,24, Ansgar Schulz25*, Johanna Schrum, MD26*, Petr Sedlacek, MD, PhD27,28*, Brigitte Strahm, PhD29,30*, Wilhelm Woessmann31*, Rupert Handgretinger, MD, PhD2, Martin Zimmermann, PhD32* and Arndt Borkhardt33
1Hannover Medical School, Hannover, Germany
2Dpt. I - General Pediatrics, Hematology and Oncology, University Children's Hospital Tübingen, Tübingen, Germany
3Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
4Universitätsklinikum Frankfurt Goethe-Universität, Frankfurt, Germany
5Department of Pediatrics, Division for Stem Cell Transplantation and Immunology, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany
6Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany
7Department of Pediatrics, University Hospital Würzburg, Würzburg, Germany
8Pediatric Hematology and Oncology, University Hospita of Heidelberg, Heidelberg, DEU
9Department of Pediatrics, Department of Pediatrics, Jena, Germany
10St.Anna Children's Hospital, Vienna, Vienna, AUT
11Goethe University, Frankfurt, DEU
12University Hospitals of Essen, Essen, DEU
13Department of Pediatric Hematology and Oncology, Justus-liebig-University, Giess, Giessen, DEU
14Division of Pediatric Stem Cell Therapy, Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich-Heine-University, Duesseldorf, Germany
15Pediatric Hematology and Oncology, University Hospital Hamburg Eppendorf, Hamburg, DEU
16Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, University Medical Center Freiburg, Germany, Freiburg, Baden Württemberg, Germany
17St. Anna Children's Hospital, Vienna, Austria, Austria
18Department of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Vienna, Austria
19University Children’s Hospital Essen. Department of Pediatric Hematology and Oncology, Essen, Germany
20University Medicine Essen, University Children’s Hospital III, AML BFM Study Group, Essen, Germany
21University Hospital Muenster, Department of Paediatric Hematology, Oncology and BMT and NHL-BFM study center, Münster, Germany
22Department Pediatric Hematology, Oncology and BMT, University Hospital Muenster, Muenster, Germany
23Bavarian Cancer Research Center (BZKF), R/R ALL Study Group, Bavaria, Germany
24Pediatric Hematology and Oncology and Stem Cell Transplantation, University Children's Hospital Wuerzburg, Wuerzburg, Germany
25Pediatric Hematology and Oncology, University Hospital Ulm, Ulm, DEU
26Pediatric Hematology and Oncology, University Hospital Hamburg Eppendorf, Hamburg, Germany
27Department of Pediatric Hematology–Oncology, University Hospital Motol, Charles University, Prague, Czech Republic
28University Hospital Motol, Department of Paediatric Haematology and Oncology, Prague, Czech Republic
29Division of Pediatric Hematology and Oncology, Department of Pediatric and Adolescent Medicine, University Hospital Freiburg, Freiburg, Germany
30Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, University Medical Center Freiburg, Germany, Freiburg, Germany
31University Medical Center Hamburg-Eppendorf, Hamburg, Germany
32Department of Pediatric Hematology and Oncology, Medical School Hannover, Hannover, Germany
33Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University Düsseldorf, Duesseldorf, Germany
Urbain Tauveron-Jalenques1*, Zofia Gross, MD2*, Martin Carre, MD3*, Emmanuelle Tavernier, MD4*, Jérôme Cornillon4*, Adrien Contejean5*, Clemence Santana6,7*, Clément Rocher, MD8*, Sylvain Lamure, MD, PhD9*, Natacha Mauz5*, Ugo Thévenet, MD10*, Boullanger Fow Heng Nadine11*, Pica Gian-Matteo12*, Dony Arthur, MD13*, Amine Belhabri, MD14*, Mauricette Michallet, MD, PhD14, Pedro Chorao, MD15*, Mael Heiblig16,17* and Gaspar Aspas Requena, MD1,18*
1Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Clermont-Ferrand, Clermont-Ferrand, France
2Département d'Hématologie, CHU de Lyon, Pierre-Bénite, France
3Clinical Hematology Department, CHU Grenoble Alpes - Université Grenoble Alpes, Grenoble, France
4Département d'hématologie Clinique et de Thérapie Cellulaire, CHU Saint-Etienne, Saint-Etienne, France
5Département d'Hématologie, Centre Hospitalier Annecy Genevois, Epagny Metz-Tessy, France
6Centre Léon Bérard, LYON CEDEX 08, France
7CH Valence, Valence, FRA
8Département d'Hématologie, Centre Hospitalier Bourgoin Jallieu, Bourgoin Jallieu, France
9Département d'Onco-Hématologie, Hôpitaux Nord-Ouest, Villefranche-sur-Saone, France
10CH de Roanne, Roanne, France
11Département d'hématologe, CH Roanne, Roanne, France
12Service d’hématologie, CH Métropole Savoie, Chambéry, France
13Service d'hematologie, Hopital Chambery, Chambery, France
14Département de Cancérologie médicale, Centre Léon Bérard, Lyon, France
15Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain
16Centre Hospitalier Lyon Sud, Centre Hospitalier Lyon Sud, Service Hématologie, Centre d’Investigation des thérapeutiques en oncologie et hématologie de Lyon (CITHOL), Vourles, Rhône Alpes, France
17Service d'hématologie clinique, Hospices Civils de Lyon, Hôpital Lyon Sud, Pierre-Bénite, France
18Université Clermont Auvergne, Clermont-Ferrand, France
Marta Peña1*, Giulia Losi, MD1,2*, Marco Aurelio Salvino, PhD1,3, David A. Qualls, MD4, Jennifer L. Crombie, MD5, Jacopo Mariotti6*, Stefania Bramanti6*, Nicole Fabbri1,7*, Angel Serna, MD8*, Yasmina I.M. Serroukh9*, Aitana Balaguer Rosello, MD, PhD10*, Marjolein W.M. van der Poel11*, Ya Ting Hsu12*, Ana Jiménez Ubieto13*, Christopher McKinnely14*, Blanca Rius-Sansalvador15,16*, Felipe Peña, MD1*, Lucia Lopez Corral, MD17*, Carlos Panizo, MD, PhD18*, Jose Antonio Pérez-Simón, MD, PhD19, Montserrat Rovira, MD, PhD20*, Sebastián Garzón, MD, PhD21*, Mi Kwon, MD, PhD22, David Valcarcel, MD, PhD8, Rosario Varela23*, Jaime Sanz10*, Andres Sanchez Salinas, MD24*, Manuel Jurado, MD, PhD25, Maria Calbacho, MD26*, Carmen Albo Lopez, Hematologist MD, PhD27*, Maria Del Mar Perera Alvarez, MD28*, Inmaculada Heras, MD29*, Leyre Bento De Miguel30*, Philippe Armand, MD, PhD31, Anna Sureda Balari, MD, PhD32,33 and Alberto Mussetti1*
1Clinical Hematology Department, Institut Català d’Oncologia-Hospitalet, IDIBELL, Barcelona, Spain
2Department of Molecular Medicine, University of Pavia, Pavia, Italy
3Hematology Department, Hospital São Rafael – IDOR / PPGMS-UFBa, Salvador, Brazil, Salvador, Brazil
4Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
5Dana-Farber Cancer Institute, Boston, MA
6Bone Marrow Transplantation and Cell Therapy Unit, Humanitas Clinical and Research Center, Rozzano, Italy
7Institute of Hematology “L. e A. Seràgnoli”, University of Bologna, Bologna, Italy
8Hematology Department, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
9Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Leuven, Belgium
10Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain
11Department of Internal Medicine, Division of Hematology, GROW school for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, Netherlands
12Division of Hematology, Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan
13Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
14Hematology Department, Fiona Stanley Hospital, Murdoch, Australia
15Institut d’Investigacio Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain
16Catalan Institute of Oncology (ICO), Unit of Biomarkers and Suceptibility (UBS), Oncology Data Analitics (ODAP), Barcelona, Spain
17Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), Salamanca, Spain
18Department of Hematology, Hospital Universitario de Donostia, San Sebastian, Spain
19Department of Hematology, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS), CSIC, University of Sevilla, Sevilla, Spain
20Hematopoietic Transplantation Unit, Hematology Department, Clinical Institute of Hematology and Oncology (ICMHO), Hospital Clínic de Barcelona, Barcelona, Spain
21Hematology, Hospital Universitario Jerez de la Frontera, Jerez de la Frontera, Cádiz, Spain
22Department of Hematology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
23Hematology Department, Complejo Hospitalario Universitario A Coruña, A Coruna, Spain
24Hematology Department, Hospital Universitario Virgen de la Arrixaca., Murcia, Spain
25Department of Hematology, Hospital Virgen De Las Nieves, Granada, Spain
26Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Madrid, Spain
27Hematology Department, Complexo Hospitalario Universitario de Vigo, Instituto de Investigación Biomédica Galicia Sur (IIBGS)., Vigo, Spain
28Hematology Department, Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria., Spain
29Hematology Division, Hospital Morales Meseguer, Murcia, Spain
30Hematology Department, Son Espases University Hospital, IdISBa, Palma, Spain
31Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA
32Hematology Department, Institut Català d'Oncologia - Hospitalet, IDIBELL, University of Barcelona, Barcelona, Spain
33Bellvitge Health Sciences Campus, University of Barcelona, Barcelona, Spain
Anush Aram Ginosyan, MD1*, Karam Ashouri, MD2*, Brian Hom2*, Brandon Ann2*, Robert Ireland, MD2*, Mollee I. Chu, MD2*, Yekta Rahimi, MD2*, Eljie Isaak Bragasin2*, Lauren Ford2*, Lucas Humayun2*, Mihir Baya2*, Danielle Hong2*, Elaine Huang2*, Preet M. Chaudhary, MD, PhD3, Amir Ali, PharmD, BCOP4, Imran Siddiqi, MD, PhD5*, Karrune Woan, MD, PhD3*, Eric L. Tam, MD3*, Abdullah Ladha, MD3* and George Yaghmour, MD3
1Keck School of Medicine, University of Southern California, Chatsworth, CA
2Keck School of Medicine, University of Southern California, Los Angeles, CA
3Jane Anne Nohl Division of Hematology and Center for the study of Blood disease, Division of Hematology, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA
4Department of Pharmacy, University of Southern California, Norris Comprehensive Cancer Center, los angeles, CA
5University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA
Andie Fu1*, Mengyuan Li2*, Yizhou Peng3*, Bin Xu3*, Li Li4*, Jin-song Jia, MD5*, Yan Yang, MD6*, Shengyun Lin7*, Jia Wei3, Fankai Meng3*, Donghua Zhang3* and Guangsheng He8*
1Tongji, Wuhan, China
2Department of hematology, Taihe Hospital, Hubei University of Medicine, Shiyan, China
3Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
4Department of hematology, Xinqiao Hospital, Army Medical University, Chongqing, China
5Peking University People’s Hospital,Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China
6Department of Hematology, The First Hospital of Jilin University, Changchun, China
7Department of Hematology, Zhejiang Province Hospital of TCM, The First Affiliated Hospital of Zhejiang TCM University, Zhejiang, China
8Jiangsu Province Hospital, Nanjing, China
Ahsan Wahab, MD1, Karen Sweiss, PharmD2 and Matias Sanchez, MD2
1University of Illinois at Chicago, Chicago, IL
2Division of Hematology/Oncology, University of Illinois Cancer Center, Chicago, IL
Shuichi Mizuta, MD1, Tomotaka Ugai, MD, PhD2*, Satoshi Nishiwaki, MD, PhD3*, Noriko Doki4, Takahiro Fukuda5*, Tetsuya Nishida, MD PhD6*, Yuta Katayama, MD, PhD7, Shuichi Ota, MD, PhD8, Yuta Hasegawa, MD, PhD9*, Masatsugu Tanaka, MD10*, Makoto Onizuka11, Tatsuo Ichinohe, MD, PhD12, Koji Kawamura, MD, PhD13*, Yoshiko Atsuta, MD, PhD14* and Yasuyuki Arai, MD, PhD15
1Internal medicine & Hematology/Immunology, Kanazawa Medical University, Uchinada, Kahoku-gun, Japan
2Faculty Member, Cancer Epidemiology Program, Dana-Farber / Harvard Cancer Center, Boston, MA
3Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan
4Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
5Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
6Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan
7Department of Hematology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan
8Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan
9Department of Hematology, Hokkaido University Faculty of Medicine and Graduate School of Medicine, Sapporo, Japan
10Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan
11Department of Hematology/Oncology, Tokai University, Isehara, Japan
12Research Institute for Radiation Biology and Medicine, Hiroshima University Department of Hematology and Oncology, Hiroshima, Japan
13Division of Hematology and Clinical Laboratory Medicine, Tottori University Hospital, Yonago, Japan
14Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan
15Department of Hematology, Kyoto University Hospital, Kyoto, Japan
Jaime Sanz1*, Allain-Thibeault Ferhat2*, Aleksander Kulagin3*, Nicolaus Kröger, MD4*, Montserrat Rovira, MD, PhD5,6*, Lorenzo Lazzari7*, Mutlu Arat8*, Juan Montoro, MD, PhD9*, Jurjen Versluis, MD, PhD10*, Péter Pál Reményi, MD11*, Simona Sica, MD, PhD12*, Didier Blaise, MD13*, Muhammad Saif14*, Jan Vydra, MD, PhD15*, Franca Fagioli, MD, PhD16*, Erfan Nur, MD, PhD17, Sebastian Giebel, MD, PhD18*, Simona Piemontese19*, Mohamad Mohty, MD, PhD20 and Fabio Ciceri, MD21,22*
1Hematology Department, Hospital Universitari i Politècnic La Fe, Departament de Medicina Universitat de Valencia, CIBERONC, Instituto Carlos III, Spain, VALENCIA, Spain
2EBMT Statistical Unit, Sorbonne University, Saint-Antoine Hospital, AP-HP, INSERM UMRs 938, Paris, France
35RM Gorbacheva Research Institute, Pavlov University, St Petersburg, RUS
4University Medical Center Hamburg, Hamburg, Germany
5Hematopoietic Transplantation Unit, Hematology Department, Clinical Institute of Hematology and Oncology (ICMHO), Hospital Clínic de Barcelona, Barcelona, Spain
6Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain
7Hematology Department - *cofirst author, IRCCS Ospedale San Raffaele, Milano, ITA
8Demiroglu Bilim University Istanbul Florence Nightingale Hospital, Istanbul, Turkey
9Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain
10Erasmus University Medical Center Cancer Institute, Rotterdam, Netherlands
11Department of Hematology and Stem Cell Transplantation, Central Hospital of Southern Pest, National Institute of Hematology and Infectious Diseases, Budapest, Hungary
12Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica Sacro Cuore, Rome, Italy
13Programme de Transplantation & Therapie Cellulaire, Marseille, France
14The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, GBR
15Institute of Haematology and Blood Transfusion, Prague, Czech Republic
16Ospedale Infantile Regina Margherita, Torino, Italy, Torino, Italy
17Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, Netherlands
18Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
19Hematology and Bone Marrow transplant Unit, San Raffaele Scientific Institute IRCCS, Milano, Milano, Italy
20Sorbonne University, Hôpital Saint-Antoine, and INSERM UMRs938, Paris, France
21Hematology and Bone Marrow Transplantation Unit, I.R.C.C.S. San Raffaele Scientific Institute, Milan, Italy
22Vita-Salute San Raffaele University, Milan, Italy
Normann Steiner1*, Evgeny Klyuchnikov, M.D.2*, Anita Badbaran, M. Sc.3*, Radwan Massoud, MD, BS4*, Gabriele Zeck2*, David Nachbaur, M.D.1*, Dominik Wolf, M.D.1*, Nico Gagelmann, MD2*, Christian Niederwieser, M.D.2*, Catherina Lück, M.D.2*, Dietlinde Janson, M.D.3*, Christine Wolschke, M.D.3*, Francis A. Ayuk, M.D.3* and Nicolaus Kroeger, M.D.3
1University Hospital of Internal Medicine V (Hematology and Oncology), Medical University of Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria
2Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany
3Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
4Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Hamburg, Germany
Jennifer Marvin-Peek, MD1, Hagop M. Kantarjian, MD1, Wei-Ying Jen, MD, FRCPath, MA1*, Gautam Borthakur, MD2, Naval Daver, MD3, Abhishek Maiti, MBBS4, Nicholas J. Short, MD1, Steven M. Kornblau, MD1, Naveen Pemmaraju, MD1, Eitan Kugler, MD PhD1*, Alexandre Bazinet, MD1*, Yesid Alvarado Valero, MD1, Hussein A. Abbas, MD, PhD1, Guillermo Garcia-Manero, MD1, Uday Popat, MD5, Elizabeth J. Shpall, MD5, Farhad Ravandi, MBBS6, Courtney D. DiNardo, MD, MSc1 and Tapan M. Kadia, MD1
1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3MD Anderson Cancer Center, Houston, TX
4Department of Leukemia, The University of Texas Health Science Center At Houston, Houston, TX
5Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
6Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
Yang-Liu Shao1*, Jingjing Yang1*, Xiaobo Li2*, Di Guan2*, Xiawei Zhang1*, Wu Tong3*, Zeliang Song4*, Dao Wang5*, Zhijie Wei6*, Jingbo Wang7*, Xiangjun Liu, PhD2*, Yuelin He, MD8*, Liping Dou, MD1 and Daihong Liu, MD9*
1The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China
2Beijing BFR Gene Diagnostics LTD., Beijing, China
3Department of Bone Marrow Transplantation, Beijing GoBroad Boren Hospital, Beijing, China
4Department of Pediatric Hematology, Children’s Hospital, Beijing, China
5Department of Pediatrics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
6Beijing Lu Daopei Hospital, Beijing, China
7Aerospace Center Hospital, Beijing, China
8Department of Pediatrics, Nanfang Hospital, Guangzhou, China
9Department of Hematology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China
Warren B Fingrut, MD, MPH1, KaNoisha Codrington1*, Ligny Hunter1*, Ricky Garcia1*, Charles Martinez1*, Gabriela Rondon, MD1, Denái R. Milton, MS2*, Christopher R. Flowers, MD, MS3 and Elizabeth J. Shpall, MD1
1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX